Balyasny Asset Management
CTIC

Balyasny Asset Management’s CTI BioPharma Corp. (DE) Common Stock CTIC Stock Holding History

Balyasny Asset Management’s Portfolio CTIC Stock Details CTIC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
2022
Q4 		$5.24M Buy
2022
Q3 		– Sell
2022
Q2 		$611K Buy
2022
Q1 		$206K Buy
2019
Q2 		– Sell
2019
Q1 		$212K Sell
2018
Q4 		$677K Buy
2018
Q3 		$648K Sell
2018
Q2 		$1.56M Buy